TLON Insider Trading Activity and SEC Form 4 Filings
TLON insider trading summary
No open-market insider purchases or sales of Talon Therapeutics, Inc. (TLON) have been reported on SEC Form 4 in the past 12 months.
Latest TLON insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 16, 2013 | Elizabeth H Weatherman | Director | Sell | $9.1M (152,329,944 @ $0.06) |
| Jul 16, 2013 | Warburg Pincus Private Equity X, L.P. | Director | Sell | $8.5M (152,329,944 @ $0.06) |
| Jul 16, 2013 | Warburg Pincus & Co. | Director | Sell | $8.5M (152,329,944 @ $0.06) |
| Jul 16, 2013 | Warburg Pincus X Partners, L.P. | Director | Sell | $8.5M (152,329,944 @ $0.06) |
| Jul 16, 2013 | Warburg Pincus X, L.P. | Director | Sell | $8.5M (152,329,944 @ $0.06) |
| Jul 16, 2013 | Warburg Pincus X LLC | Director | Sell | $8.5M (152,329,944 @ $0.06) |
| Jul 16, 2013 | Warburg Pincus Partners LLC | Director | Sell | $8.5M (152,329,944 @ $0.06) |
| Jul 16, 2013 | Warburg Pincus LLC | 10% Owner | Sell | $8.5M (152,329,944 @ $0.06) |
| Jul 16, 2013 | Joseph P. Landy | 10% Owner | Sell | $8.5M (152,329,944 @ $0.06) |
| Jul 16, 2013 | Charles R Kaye | 10% Owner | Sell | $8.5M (152,329,944 @ $0.06) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.